Updated:
Brookhaven Capital Partners
Brookhaven Capital Partners was founded in 2013 by John D. Feltman after exits from Brookhaven Medical and Alta Biomaterials. The firm manages the resulting...
Brookhaven Capital Partners
Brookhaven Capital Partners was founded in 2013 by John D. Feltman after exits from Brookhaven Medical and Alta Biomaterials. The firm manages the resulting proprietary capital as a single-family office. Investment activity centers on direct co-investments and SPVs in real estate and infrastructure. Confirmed holdings include Cherry Creek Medical Center, a 100,000 SF medical office building completed in 2019 and fully leased to UCHealth, and Pioneer Lines, a short-line railroad operator acquired in a 2019 take-private. The firm also targets growth-stage opportunities in healthcare services, mobility and industrial tech. Activity remains concentrated in North America. The team lists four named principals and maintains offices in Greenwood Village, San Francisco, Detroit and Las Vegas. No public AUM figure or recent 24-month operational events appear in available records. The structure combines family-office capital with an operating-company track record in real assets, allowing direct ownership and hands-on management of portfolio companies rather than fund commitments.
General information
Firm type
Single Family Office
Year founded
2013
Location
Region
North America
Country
United States
City
Greenwood Village
Corporate office
5619 DTC Parkway, Suite 625, Greenwood Village, CO 80111
Additional offices
San Francisco · Detroit · Las Vegas
Principals
Robert Jacobs
Principal
James Green
Partner
Michael Hilbert
Partner
Peter Dreyfuss
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Brookhaven Capital Partners?
Robert Jacobs serves as Principal. James Green, Michael Hilbert and Peter Dreyfuss serve as Partners. No further delegation of investment authority is disclosed.
Does Brookhaven Capital Partners participate in fund commitments or only direct deals?
The firm executes direct co-investments and SPVs. No fund commitments are referenced in its materials.
What investment stages does Brookhaven Capital Partners typically target?
The firm targets growth-stage opportunities alongside control-oriented real-asset acquisitions.
Where does the underlying wealth come from?
Wealth originates from medical-device entrepreneur John D. Feltman through exits from Brookhaven Medical and Alta Biomaterials.
Which sectors does Brookhaven Capital Partners focus on?
Focus areas include real estate, infrastructure, healthcare services, mobility and transportation, and industrial tech.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: